Tag Archives: Junshi

BiodinesA number one international CDMO extends his congratulations to Junshi Biosciences (HKEX-1877; SSE-688180) for the preservation of examinations of Modern Drug (Ind) Admission of Chinas Nationwide Medical Merchandise Administration (NMPA) for JS212, a bispecific antibody conjugate (ADC), which on each EGFR and Goal on the hosprecrecige receptors. JS212 represents a fresh class of biston-specific ADCs […]